Archive: Testing for Thrombotic Risk using Thrombin Generation and Microparticle Flow Cytometry

Coag's Future - Testing for Thrombotic Risk using Thrombin Generation and Microparticle Flow Cytometry Dr. Wayne Chandler of the University of Washington reviews the current status of assays to predict the risk of thrombosis in patients and presents two new assays that show promise for improving risk assessments in the future. Thrombin generation assays provide an integrated measure of venous thrombotic risk. Plasma microparticle assays indicate risk of arterial thrombosis and cancer associated thrombosis. Wayne Chandler, MD, Professor, Laboratory Medicine; Chief, Service, Harborview Medical Center, University of Washington http://depts.washington.edu/labweb/ Oct 15, 2010 The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at [email protected].